Status:
NOT_YET_RECRUITING
Stereotactic Radiosurgery Prognosis Assessment for Spinal Tumors Based on Radiomics
Lead Sponsor:
Zhuang Hongqing
Conditions:
Stereotactic Radiosurgery
Spinal Tumor
Eligibility:
All Genders
18-80 years
Brief Summary
This study aims to assess multimodal Radiomics-based prediction model for prognostic prediction in spinal tumors.
Detailed Description
Sensitivity for prediction recurrence and survival of currently available prognostic scores is limited. This study proposes to establish a multimodal radiomics model for identifying tumor recurrence a...
Eligibility Criteria
Inclusion
- A diagnosis of spinal tumors for which SBRT is appropriate Karnofsky Performance Status \>60 Life expectancy of at least 3 months No contraindication to undergoing MR imaging Age \>18 Complete the CT MRI or PET-CT examination before and after treatment Accept stereotactic radiosurgery
Exclusion
- Subjects unable to undergo MRI (includes non-MRI compatible material or devices and severe claustrophobia) Subjects with prior procedural intervention to the involved vertebral body that would result in artifact (kyphoplasty, screw and/or rod placement); minimally invasive surgery without instrumentation of the involved vertebral body and instrumentation immediately above or below the index lesion is allowed.
- Subjects with spinal cord compression; minimally invasive "separation" surgery to first resect the epidural component is allowed Pregnant or breast-feeding women Allergy to standard IV contrast agents used in MRI
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05369689
Start Date
June 1 2022
End Date
June 1 2027
Last Update
May 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology Cancer Center, Peking University Third Hospital 49# North Garden Rd.,Haidian Dist.
Beijing, Beijing Municipality, China, 100191